cardiovascular risk factor and inflammatory markers. Atherosclerosis
Conditions
Interventions
Intervention 1: Subjects in high intensitiy resistance group undergwent exercise regime consist of three sessions of resistance training per week for six consecutive weeks. In each session they did th
Subjects in high intensitiy resistance group undergwent exercise regime consist of three sessions of resistance training per week for six consecutive weeks. In each session they did three sets of 4-6
Subjects in moderate intensitiy resistance group undergwent exercise regime consist of three sessions of resistance training per week for six consecutive weeks. In each session they did three sets of
Subjects of the control group did not do any regular physical activities during the period of study.
Sponsors
Kurdistan University of Medical Sciences, vice chancellor for research
Eligibility
Sex/Gender
Male
Age
20 Years to 26 Years
Inclusion criteria
Inclusion criteria: Inclusion Criteria: Healthy young students with no previous record of any specific drug use and routine regular exercises during the last two years. Exclusion: Unhealthy, Doing regular exercise during the last two years.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Triglyceride, High-density lipoprotein, Low-density lipoprotein,Total cholesterol ,ApoA, ApoB. Timepoint: 6 weeks. Method of measurement: by collecting venous blood and measuring serum levels of related variables before and at the end of the study.;Lipoprotein Lipase. Timepoint: 6 weeks. Method of measurement: by collecting venous blood before and at the end of study and measuring serum levels using LPL kit.;Interleukin1 and Interleukin 6. Timepoint: 6 weeks. Method of measurement: by collecting venous blood before and at the end of study and measuring serum levels of related factors using Enzyme-linked immunosorbent assay (ELISA).;Hs-CRP (high-sensitivity CRP) and fibrinogen. Timepoint: 6 weeks. Method of measurement: by collecting venous blood before and at the end of study and measuring serum levels using related kits.;Body Mass Index. Timepoint: 6 weeks. Method of measurement: bybody composition analyzer (Biospase CO, Ltd).;Waist Hip Ratio. Timepoint: 6 weeks. Method of measurement: By measuring Hip and Waist circumferences by measuring tape.;Systolic and diastolic Blood pressure. Timepoint: 6 weeks. Method of measurement: sphygmomanometer. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSlahadin Ahmadi
Kurdistan University of Medical Sciences
Outcome results
None listed